drugset / Trial / NCT00883727
Ex Vivo Cultured Bone Marrow Derived Allogenic MSCs in AMI
RandomizedParallel-groupTriple-blindTreatment
Summary
This clinical trial aims to find out the safety and efficacy of adult mesenchymal stem cells in patients with myocardial infarction.
Timeline
- Start
- 2009-04
- Primary completion
- 2010-05
- Completion
- 2012-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Stempeucel® | Cell therapy | — | Intravenous |